These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1155997)

  • 1. The experimental chemotherapy of leishmaniasis. II. The activity in tissue culture of some antiparasitic and antimicrobial compounds in clinical use.
    Mattock NM; Peters W
    Ann Trop Med Parasitol; 1975 Sep; 69(3):359-71. PubMed ID: 1155997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The experimental chemotherapy of leishmaniasis. I: Techniques for the study of drug action in tissue culture.
    Mattock NM; Peters W
    Ann Trop Med Parasitol; 1975 Sep; 69(3):349-57. PubMed ID: 1171658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis.
    Trotter ER; Peters W; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):299-319. PubMed ID: 7396564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.
    Berman JD; Lee LS
    J Parasitol; 1984 Apr; 70(2):220-5. PubMed ID: 6088749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity.
    Peters W
    Ann Trop Med Parasitol; 1975 Jun; 69(2):155-71. PubMed ID: 1098584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners.
    Huang TL; Vanden Eynde JJ; Mayence A; Donkor IO; Khan SI; Tekwani BL
    J Pharm Pharmacol; 2006 Aug; 58(8):1033-42. PubMed ID: 16872549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of rodent malaria, XXIII Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening.
    Peters W; Davies EE; Robinson BL
    Ann Trop Med Parasitol; 1975 Sep; 69(3):311-28. PubMed ID: 1098590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
    Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
    J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
    Werbovetz K
    Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum.
    Rosypal AC; Hall JE; Bakunova S; Patrick DA; Bakunov S; Stephens CE; Kumar A; Boykin DW; Tidwell RR
    Vet Parasitol; 2007 Apr; 145(3-4):207-16. PubMed ID: 17298866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiparasitic activity of a triphenyl tin complex against Leishmania donovani.
    Raychaudhury B; Banerjee S; Gupta S; Singh RV; Datta SC
    Acta Trop; 2005 Jul; 95(1):1-8. PubMed ID: 15896700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania.
    Wong IL; Chan KF; Zhao Y; Chan TH; Chow LM
    J Antimicrob Chemother; 2009 Jun; 63(6):1179-90. PubMed ID: 19377065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
    Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR
    J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N'-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides.
    Bernardino AM; Gomes AO; Charret KS; Freitas AC; Machado GM; Canto-Cavalheiro MM; Leon LL; Amaral VF
    Eur J Med Chem; 2006 Jan; 41(1):80-7. PubMed ID: 16300859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agents.
    Cruz LJ; Luque-Ortega JR; Rivas L; Albericio F
    Mol Pharm; 2009; 6(3):813-24. PubMed ID: 19317431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
    Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
    Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of nicotinamide/antileishmanial drug combinations.
    Gazanion E; Vergnes B; Seveno M; Garcia D; Oury B; Ait-Oudhia K; Ouaissi A; Sereno D
    Parasitol Int; 2011 Jan; 60(1):19-24. PubMed ID: 20884376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmanicidal activity of aurones.
    Kayser O; Kiderlen AF
    Tokai J Exp Clin Med; 1998 Dec; 23(6):423-6. PubMed ID: 10622641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro leishmanicidal activity of aurones.
    Kayser O; Kiderlen AF; Folkens U; Kolodziej H
    Planta Med; 1999 May; 65(4):316-9. PubMed ID: 10364835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.